Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Chemical Properties and Applications of Substance with CAS Number 202647-50-9

Nov . 06, 2024 03:31 Back to list

Chemical Properties and Applications of Substance with CAS Number 202647-50-9



Exploring the Compound with CAS Number 202647-50-9


In the world of chemistry, unique compounds are assigned specific identifiers known as Chemical Abstracts Service (CAS) numbers. Each number is a unique identifier that allows researchers and scientists to easily reference and locate specific substances within extensive chemical literature. One such compound is identified by the CAS number 202647-50-9.


The CAS number 202647-50-9 corresponds to a chemical known as Lurasidone. This compound is notable for its pharmacological applications, particularly in the treatment of psychiatric disorders. Lurasidone is classified under atypical antipsychotics and is primarily prescribed for the treatment of schizophrenia and bipolar depression. Atypical antipsychotics are favored in modern medicine due to their ability to treat symptoms with a lower risk of side effects compared to older antipsychotic medications.


Lurasidone was first approved for medical use in the United States in 2010 and has since gained attention for its efficacy and tolerability profile. The drug works by modulating the activity of several key neurotransmitters in the brain, particularly dopamine and serotonin. By blocking certain dopamine receptors while simultaneously acting as an agonist at serotonin receptors, Lurasidone helps to alleviate symptoms of psychosis and mood disorders. This dual action is crucial as it addresses both positive symptoms, such as hallucinations and delusions, and negative symptoms, such as social withdrawal and apathy.


Exploring the Compound with CAS Number 202647-50-9

Moreover, Lurasidone has shown promising results in clinical trials, demonstrating its effectiveness in reducing the severity of depressive episodes in individuals with bipolar disorder. The ability to stabilize mood swings and improve overall quality of life makes Lurasidone a valuable asset in the therapeutic arsenal for mental health practitioners.


cas 2647-50-9

Chemical Properties and Applications of Substance with CAS Number 202647-50-9

While Lurasidone exhibits significant therapeutic benefits, it is not without its risks and side effects. Common side effects may include somnolence (drowsiness), akathisia (a feeling of inner restlessness), nausea, and anxiety. It is essential for healthcare providers to monitor patients closely, especially during the initial stages of treatment, to ensure that any adverse effects are managed promptly.


The prescription of Lurasidone must be tailored to each individual's unique needs, taking into account their medical history, current medications, and potential drug interactions. Physicians often conduct a thorough assessment before initiating treatment to ensure the best outcomes for their patients.


In addition to the clinical aspects, Lurasidone raises important discussions surrounding the broader landscape of mental health treatment. The stigma associated with psychiatric disorders can deter individuals from seeking help, and the development of effective treatments like Lurasidone is a step forward in normalizing conversations about mental health. By effectively managing symptoms, patients can lead more fulfilling lives, contributing to their communities and personal relationships.


As research continues to evolve, the understanding of compounds like Lurasidone and their real-world applications in psychiatry will undoubtedly deepen. The growing body of literature surrounding Lurasidone will guide clinicians in making informed decisions about treatment options, ultimately improving care for individuals living with schizophrenia and bipolar disorder.


In conclusion, the CAS number 202647-50-9 represents a significant advancement in the world of pharmacotherapy for mental health disorders. Lurasidone not only exemplifies the progress made in developing effective, safe medications but also highlights the ongoing need for research and dialogue in the realm of psychiatry. As we continue to explore the complexities of mental health, compounds like Lurasidone provide hope for better treatment outcomes and improved quality of life for countless individuals.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
zuZulu
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu